Bionano Genomics
NASDAQ: BNGOSan Diego, US · Delaware corporation · 1 known investors
Founders & leadership
HC
Han CaoFounder
GK
Gulsen KamaExecutive
MO
Mark OldakowskiExecutive
JD
Jonathan DixonExecutive
RE
R. Erik HolmlinExecutive
AC
Alka ChaubeyExecutive
ER
Erik R. HolmlinExecutive
JJ
Joel JungExecutive
LR
Lynne RollinsExecutive
Board
DC
Darren CaiBoard director
BH
YL
Yvonne LinneyBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$192.8M disclosed across 8 rounds · 2013–2024
▶$20MraisedJul 2024 · 2 investors · BiotechnologyRule 506(b)
▶$20MraisedJul 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Yvonne LinneyDirector
- Gulsen KamaExecutive Officer
- David L. BarkerDirector
- Kristiina VuoriDirector
- Christopher TwomeyDirector
- Mark OldakowskiExecutive Officer
- Jonathan DixonExecutive Officer
- Hannah MamuszkaDirector
- R. Erik HolmlinExecutive Officer, Director
- Albert A. LudererDirector
- Vincent WongDirector
- Alka ChaubeyExecutive Officer
- Aleksandar RajkovicDirector
- Offering amount
- $20M
- Amount sold
- $20M
- Sales commissions
- $400K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$20MraisedJun 2024 · 4 investors · BiotechnologyRule 506(b)
▶$20MraisedJun 2024 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- R. Erik HolmlinExecutive Officer
- Offering amount
- $20M
- Amount sold
- $20M
- Minimum investment
- $100K
- Sales commissions
- $1.3M
- Placement agents
- Canaccord Genuity LLC
- First sale
- May 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$35MraisedOct 2023 · 1 investors · Other Health CareRule 506(b)
▶$35MraisedOct 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Alka Chaubey, Ph.D., FACMGExecutive Officer
- Vincent Wong, J.D., M.B.A.Director
- Mark OldakowskiExecutive Officer
- Albert A. Luderer, Ph.D.Director
- Gulsen KamaExecutive Officer
- Kristiina Vuori, M.D., Ph.D.Director
- Christopher TwomeyDirector
- Hannah MamuszkaDirector
- David L. Barker, Ph.D.Director
- Aleksandar Rajkovic, M.D., Ph.D.Director
- Yvonne Linney, Ph.D.Director
- R. Erik Holmlin, Ph.D.Executive Officer, Director
- Offering amount
- $35M
- Amount sold
- $35M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$41.9MraisedOct 2021 · 27 investors · Other Health CareRule 506(b)
▶$41.9MraisedOct 2021 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Christopher TwomeyDirector
- R. Erik Holmlin, Ph.D.Executive Officer, Director
- David L. Barker, Ph.D.Director
- Albert A. Luderer, Ph.D.Director
- Kristiina Vuori, M.D., Ph.D.Director
- Soheil ShamsExecutive Officer
- Hannah MamuszkaDirector
- Richard ShippyExecutive Officer
- Alka Chaubey, Ph.D., FACMGExecutive Officer
- Yvonne Linney, Ph.D.Director
- Christopher StewartExecutive Officer
- Jason PriarExecutive Officer
- Mark OldakowskiExecutive Officer
- Offering amount
- $41.9M
- Amount sold
- $41.9M
- First sale
- Oct 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedMar 2019 · 3 investors · PharmaceuticalsRule 506(b)
▶$2.5MraisedMar 2019 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Albert Luderer, Ph.D.Director
- Junfeng WangDirector
- Quan ZhouDirector
- R. Erik Holmlin, Ph.D.Executive Officer, Director
- Warren RobinsonExecutive Officer
- Mike WardExecutive Officer
- Christopher TwomeyDirector
- David L. Barker, Ph.D.Director
- Darren Cai, Ph.D.Director
- Mark BorodkinExecutive Officer
- Offering amount
- $11.5M
- Amount sold
- $2.5M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$68.4MraisedJan 2015 · 17 investors · PharmaceuticalsRule 506(b)
▶$68.4MraisedJan 2015 · 17 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David BarkerDirector
- Darren CaiDirector
- Brian HalakDirector
- Campbell MurrayDirector
- Albert LudererDirector
- Erik R. HolmlinExecutive Officer, Director
- Tracy WarrenDirector
- Joel JungExecutive Officer
- Han CaoExecutive Officer
- Offering amount
- $68.4M
- Amount sold
- $68.4M
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5MraisedJun 2014 · 5 investors · PharmaceuticalsRule 506(b)
▶$5MraisedJun 2014 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David L. BarkerDirector
- R. Erik HolmlinExecutive Officer
- Joel R. JungExecutive Officer
- Albert A. LudererDirector
- Han CaoExecutive Officer
- Tracy WarrenDirector
- Brian HalakDirector
- Offering amount
- $6.1M
- Amount sold
- $5M
- First sale
- Jun 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15KraisedJan 2014 · 1 investors · PharmaceuticalsRule 506(b)
▶$15KraisedJan 2014 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- R. Erik HolmlinExecutive Officer, Director
- David L. BarkerDirector
- Han CaoExecutive Officer
- Tracy WarrenDirector
- Brian HalakDirector
- Lynne RollinsExecutive Officer
- Albert A. LudererDirector
- Offering amount
- $15K
- Amount sold
- $15K
- First sale
- Dec 2013
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- Who founded Bionano Genomics?
- Bionano Genomics was founded by Han Cao.
- Who are Bionano Genomics's investors?
- Bionano Genomics's investors include Domain Associates.
- How much funding has Bionano Genomics raised?
- Bionano Genomics has disclosed $192.8M raised across 8 rounds.
- Where is Bionano Genomics headquartered?
- Bionano Genomics is headquartered in San Diego, US.